Availability, price, and affordability of medicines used for the management of Covid-19 in health facilities of Dessie town WHO/HAI survey

• Published in: PloS one Vol. 17; no. 12; p. e0279465
• Main Authors: Mohammed, Solomon Ahmed, Tsehay, Tessema, Faris, Abebe Getie, Mengstu, Getnet
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 21.12.2022; Public Library of Science (PLoS)
• Subjects: Availability; Coronaviruses; Costs and Cost Analysis; COVID-19; COVID-19 - epidemiology; Cross-Sectional Studies; Data collection; Developing countries; Disease transmission; Drug dosages; Drug stores; Drugs, Essential; Drugs, Generic; Earth Sciences; Evaluation; Health care facilities; Health Facilities; Health Services Accessibility; Hospitals; Humans; LDCs; Medical care, Cost of; Medical supplies; Medicine; Medicine and Health Sciences; Mortality; Pandemics; Pharmacists; Physical Sciences; Prices; Private Sector; Public health; Public sector; Retrospective Studies; Severe acute respiratory syndrome coronavirus 2; Shortages; Social Sciences; Supply chains; Viruses; World Health Organization; Ethiopia; Bangladesh; Nigeria; Rwanda
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0279465

The rapidly spreading nature of Covid-19 virus associated with its high mortality and mortality rate is triggering an unprecedented public health crisis. The study assessed the availability, price, and affordability of medicines used in the management of Covid-19 in health facilities of Dessie town. A retrospective cross-sectional study design was employed in the health facilities of Dessie town from September 1 to September 20, 2021. Data was collected using a standard checklist adopted from the Logistics Indicator Assessment Tool and WHO/HAI. WHO/HAI methodology was applied to select the surveyed health facilities (30) and medicines (44). The daily wage of the lowest-paid unskilled government worker is used to estimate affordability. Fifteen and five medicines were not found at all public and private health facilities, respectively. The originator brand (OB) and lowest price generic (LPG) availability in private health facilities was 2.03% and 51.33%, respectively. In the public sector, the availability of OB and LPG was 0% and 34.44%, respectively. In public and private health facilities, the mean number of stock-outs was 2.25 and 2.91, and the mean number of stock-out days was 177.83 and 106.16 days, respectively. Eight and one LPG medicines were out of stock in public and private health facilities, respectively. Eight (33.33%) and 6 (28.57%) had higher prices than international prices in private and public health facilities, respectively. The median price ratio in public and private health facilities ranged from 0.02 and 3.05 and 0.04 to 2.70, respectively. Eighty percent of the products were unaffordable in both sectors. The availability of medicines was low. One-third of the medicines had higher prices than international prices. Eighty percent of the products were unaffordable. The regular supply of these medicines is crucial for better management of the disease.